RSLS Stock Summary and Trading Ideas (Reshape Lifesciences | NASDAQ:RSLS)

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Reshape Lifesciences trades on the NASDAQ stock market under the symbol RSLS.

As of April 24, 2024, RSLS stock price was flat at $0.17 with 110,646 million shares trading.

RSLS has a beta of 1.88, meaning it tends to be more sensitive to market movements. RSLS has a correlation of 0.06 to the broad based SPY ETF.

RSLS has a market cap of $3.94 million. This is considered a Sub-Micro Cap stock.

Last quarter Reshape Lifesciences reported $2 million in Revenue and -$1.02 earnings per share. This fell short of revenue expectation by $-245,000 and exceeded earnings estimates by $.18.

The top ETF exchange traded funds that RSLS belongs to (by Net Assets): VXF.

RSLS has underperformed the market in the last year with a price return of -93.9% while the SPY ETF gained +24.2%. RSLS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.3% and -3.2%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

RSLS support price is $.16 and resistance is $.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RSLS stock will trade within this expected range on the day.